Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1992 2
1993 2
1995 1
1999 1
2002 1
2008 1
2009 1
2011 1
2013 1
2015 1
2016 1
2018 1
2019 1
2020 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Understanding the etiology of Stargardt's disease.
Glazer LC, Dryja TP. Glazer LC, et al. Ophthalmol Clin North Am. 2002 Mar;15(1):93-100, viii. doi: 10.1016/s0896-1549(01)00011-6. Ophthalmol Clin North Am. 2002. PMID: 12064087 Review.
Management of expulsive choroidal hemorrhage.
Glazer LC, Williams GA. Glazer LC, et al. Semin Ophthalmol. 1993 Jun;8(2):109-13. doi: 10.3109/08820539309060218. Semin Ophthalmol. 1993. PMID: 10148653 Review. No abstract available.
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration.
Poor SH, Weissgerber G, Adams CM, Bhatt H, Browning DJ, Chastain J, Ciulla TA, Ferriere M, Gedif K, Glazer LC, Joondeph BC, Normand G, Sheth V, Watters C, Grosskreutz CL. Poor SH, et al. Among authors: glazer lc. Am J Ophthalmol. 2022 Jul;239:180-189. doi: 10.1016/j.ajo.2022.02.019. Epub 2022 Mar 2. Am J Ophthalmol. 2022. PMID: 35247334 Free article. Clinical Trial.
Choroidal rupture and optic atrophy.
Glazer LC, Han DP, Gottlieb MS. Glazer LC, et al. Br J Ophthalmol. 1993 Jan;77(1):33-5. doi: 10.1136/bjo.77.1.33. Br J Ophthalmol. 1993. PMID: 8435396 Free PMC article.
24 results